{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:04:31Z","timestamp":1757617471810,"version":"3.44.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04416-2","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T14:31:32Z","timestamp":1739284292000},"page":"2379-2386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Key strategies for reducing recurrence in T1 bladder cancer. Evidence from a retrospective multicenter European study"],"prefix":"10.1007","volume":"57","author":[{"given":"Roberto","family":"Contieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Guigui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bastien","family":"Gondran-Tellier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Basile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Zattoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Gallioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Verri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Aumatell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Lechevallier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrille","family":"Bastide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akram","family":"Akiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Amparore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura S.","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Pradere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142","family":"Rajwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy Y. C.","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Porpiglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Breda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Baboudjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Uleri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"issue":"1","key":"4416_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM, Dominguez Escrig JL et al (2022) European association of urology guidelines on non\u2013muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ). Eur Urol 81(1):75\u201394","journal-title":"Eur Urol"},{"issue":"9b","key":"4416_CR2","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/j.1464-410X.2008.07966.x","volume":"102","author":"HW Herr","year":"2008","unstructured":"Herr HW, Donat SM (2008) Quality control in transurethral resection of bladder tumours. BJU Int 102(9b):1242\u20131246","journal-title":"BJU Int"},{"issue":"10","key":"4416_CR3","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00345-018-2299-2","volume":"36","author":"J Palou","year":"2018","unstructured":"Palou J, Pisano F, Sylvester R, Joniau S, Serretta V, Larr\u00e9 S et al (2018) Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought. World J Urol 36(10):1621\u20131627","journal-title":"World J Urol"},{"issue":"5","key":"4416_CR4","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.eururo.2009.05.047","volume":"57","author":"P Mariappan","year":"2010","unstructured":"Mariappan P, Zachou A, Grigor KM, Edinburgh Uro-Oncology Group (2010) Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol 57(5):843\u20139","journal-title":"Eur Urol"},{"issue":"3","key":"4416_CR5","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden APM, Oosterlinck W, Witjes JA, Bouffioux C, Denis L et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 Bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49(3):466\u2013477","journal-title":"Eur Urol"},{"issue":"48","key":"4416_CR6","first-page":"24","volume":"20","author":"P Diana","year":"2022","unstructured":"Diana P, Baboudjian M, Gallioli A, Territo A, Fontanet S, Izquierdo P et al (2022) Implementing a checklist for transurethral resection of bladder tumor to standardize outcome reporting: when high-quality resection could influence oncological outcomes. Eur Urol Open Sci 20(48):24\u201327","journal-title":"Eur Urol Open Sci"},{"issue":"4","key":"4416_CR7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.euf.2017.09.002","volume":"5","author":"K Hendricksen","year":"2019","unstructured":"Hendricksen K, Aziz A, Bes P, Chun FKH, Dobruch J, Kluth LA et al (2019) Discrepancy between european association of urology guidelines and daily practice in the management of non-muscle-invasive bladder cancer: results of a european survey. Eur Urol Focus 5(4):681\u2013688","journal-title":"Eur Urol Focus"},{"issue":"4","key":"4416_CR8","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","volume":"79","author":"RJ Sylvester","year":"2021","unstructured":"Sylvester RJ, Rodr\u00edguez O, Hern\u00e1ndez V, Turturica D, Bauerov\u00e1 L, Bruins HM et al (2021) European association of urology (EAU) prognostic factor risk groups for non\u2013muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panel. Eur Urol 79(4):480\u2013488","journal-title":"Eur Urol"},{"issue":"5","key":"4416_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/bju.13102","volume":"116","author":"S Baltac\u0131","year":"2015","unstructured":"Baltac\u0131 S, Bozlu M, Y\u0131ld\u0131r\u0131m A, G\u00f6k\u00e7e M\u0130, Tinay \u0130, Aslan G et al (2015) Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high-risk non-muscle-invasive bladder cancer treated with maintenance intravesical Bacillus Calmette-Gu\u00e9rin. BJU Int 116(5):721\u2013726","journal-title":"BJU Int"},{"issue":"5","key":"4416_CR10","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/bju.13148","volume":"116","author":"EC Skinner","year":"2015","unstructured":"Skinner EC (2015) Is 42 days the \u2018magic number\u2019 for repeat transurethral resection of bladder tumour (TURBT)? BJU Int 116(5):678\u2013679","journal-title":"BJU Int"},{"issue":"21","key":"4416_CR11","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.3390\/cancers13215276","volume":"13","author":"M Ferro","year":"2021","unstructured":"Ferro M, Del Giudice F, Carrieri G, Busetto GM, Cormio L, Hurle R et al (2021) The impact of SARS-CoV-2 pandemic on time to primary, secondary resection and adjuvant intravesical therapy in patients with high-risk non-muscle invasive bladder cancer: a retrospective multi-institutional cohort analysis. Cancers (Basel) 13(21):5276","journal-title":"Cancers (Basel)"},{"issue":"10","key":"4416_CR12","doi-asserted-by":"publisher","first-page":"EVIDoa2200092","DOI":"10.1056\/EVIDoa2200092","volume":"1","author":"R Heer","year":"2022","unstructured":"Heer R, Lewis R, Vadiveloo T, Yu G, Mariappan P, Cresswell J et al (2022) A randomized trial of PHOTOdynamic surgery in non-muscle-invasive bladder cancer. NEJM Evid 1(10):EVIDoa2200092","journal-title":"NEJM Evid"},{"issue":"4","key":"4416_CR13","doi-asserted-by":"publisher","first-page":"e784","DOI":"10.1016\/j.clgc.2019.04.014","volume":"17","author":"M Akand","year":"2019","unstructured":"Akand M, Muilwijk T, Raskin Y, De Vrieze M, Joniau S, Van Der Aa F (2019) Quality control indicators for transurethral resection of non-muscle-invasive bladder cancer. Clin Genitourin Cancer 17(4):e784\u2013e792","journal-title":"Clin Genitourin Cancer"},{"key":"4416_CR14","unstructured":"Mariappan P, Johnston A, Trail M, Hamid S, Hollins G, Dreyer BA, et al. (2024) Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non\u2013muscle-invasive Bladder Cancer. European Urology Oncology [Internet]. 2024 Jan 30 [cited 2024 Mar 23];0(0). Available from: https:\/\/euoncology.europeanurology.com\/article\/S2588-9311(24)00037-3\/fulltext"},{"issue":"1","key":"4416_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","volume":"69","author":"S Cambier","year":"2016","unstructured":"Cambier S, Sylvester RJ, Collette L, Gontero P, Brausi MA, van Andel G et al (2016) EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non\u2013muscle-invasive stage Ta\u2013T1 urothelial bladder cancer patients treated with 1\u20133 years of maintenance Bacillus Calmette-Gu\u00e9rin. Eur Urol 69(1):60\u201369","journal-title":"Eur Urol"},{"issue":"6","key":"4416_CR16","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1097\/JU.0000000000001633","volume":"205","author":"JT Matulay","year":"2021","unstructured":"Matulay JT, Li R, Hensley PJ, Brooks NA, Narayan VM, Grossman HB et al (2021) Contemporary outcomes of patients with nonmuscle-invasive bladder cancer treated with bacillus calmette-gu\u00e9rin: implications for clinical trial design. J Urol 205(6):1612\u20131621","journal-title":"J Urol"},{"issue":"6","key":"4416_CR17","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.euo.2023.07.012","volume":"6","author":"R Contieri","year":"2023","unstructured":"Contieri R, Hensley PJ, Tan WS, Grajales V, Bree K, Nogueras-Gonzalez GM et al (2023) Oncological outcomes for patients with European association of urology very high-risk non-muscle-invasive bladder cancer treated with Bacillus Calmette-Gu\u00e9rin or early radical cystectomy. Eur Urol Oncol 6(6):590\u2013596","journal-title":"Eur Urol Oncol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04416-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04416-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04416-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T05:00:34Z","timestamp":1757134834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04416-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":17,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["4416"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04416-2","relation":{},"ISSN":["1573-2584"],"issn-type":[{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}